CAS 1346599-35-6

Formula: C21H26ClN5O

InChI: InChI=1S/C21H26ClN5O/c1-2-17-7-8-18(16-19(17)22)25-14-12-24(13-15-25)9-5-11-27-21(28)26-10-4-3-6-20(26)23-27/h3-4,6-8,10,16H,2,5,9,11-15H2,1H3

InChI key: FAKVJGFSBCIPNY-UHFFFAOYSA-N

SMILES: CCC1=C(C=C(C=C1)N2CCN(CC2)CCCN3C(=O)N4C=CC=CC4=N3)Cl

Trazodone EP Impurity E (Trazodone Hydrochloride BP Impurity E)

CAS: 1346599-35-6

Formula: C₂₁H₂₆ClN₅O

Colore e forma: White To Off-White Solid

Peso molecolare: 399.92

Ref: 4Z-T-337

Ethyl Trazodone

CAS: 1346599-35-6

Purezza: 98%

Ref: IN-DA01E1A2

Trazodone EP Impurity E

CAS: 1346599-35-6

Formula: C₂₁H₂₆ClN₅O

Peso molecolare: 399.92

Ref: ST-EA-CP-T29005

Ethyl Trazodone

Prodotto controllato

CAS: 1346599-35-6

Formula: C₂₁H₂₆ClN₅O

Colore e forma: Neat

Peso molecolare: 399.92

Ref: TR-E927100

2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one

CAS: 1346599-35-6

2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one is a research and development impurity standard. Impurities are the substances that are not intentionally added to the drug product but can be generated from the synthesis process or from the raw materials. This substance has been used as a synthetic intermediate in the production of other drugs and as an analytical reference for HPLC analysis. It is used to help develop new drugs by providing data about metabolites and possible toxic effects on humans.

Purezza: Min. 95%

Ref: 3D-IC171026